The next board meeting for Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B is on 09 Sep 2025 for the purpose of Ligand Pharmaceuticals Inc Other Guidance Call for 2025See details
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B - LGND - stock price prediction, stock price target, analyst ratings from 7 analysts
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B has a share price target of US$ 175, revenue growth forecast of 27.9%, and profit growth estimate of 213.9% for FY25, based on top 7 analyst calls.